Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

MTRAC review Cox-II NSAIDs

The Midlands Therapeutic Review and Advisory Committee (MTRAC) has reviewed the evidence for the three Cox-II NSAIDs.

They have issued review on:

The reviews covered 25 randomised controlled studies involving celecoxib, 13 involving etoricoxib and 8 involving lumiracoxib. All three reviews found that evidence of efficacy for these drugs was strong but concerns about cardiovascular safety gives this class of drugs a low place in therapy.

Action: These review provide a useful summary and reminder of the efficacy and safety evidence for Cox-II NSAIDs.

Share 'MTRAC review Cox-II NSAIDs' on Email Share 'MTRAC review Cox-II NSAIDs' on Delicious Share 'MTRAC review Cox-II NSAIDs' on Digg Share 'MTRAC review Cox-II NSAIDs' on Facebook Share 'MTRAC review Cox-II NSAIDs' on reddit Share 'MTRAC review Cox-II NSAIDs' on StumbleUpon Share 'MTRAC review Cox-II NSAIDs' on Twitter

atomic-wealth

No Comments to “MTRAC review Cox-II NSAIDs”

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer